Keyphrases
Virus
100%
Immunogenicity
100%
Modified-live Virus Vaccine
100%
Granulocyte Colony-stimulating Factor (G-CSF)
50%
Immunization
33%
Virus-specific
33%
Primates
33%
Bovine Parainfluenza Virus Type 3 (BPIV3)
33%
T Cells
16%
Serum Antibody
16%
Antibody Response
16%
Complementary DNA (cDNA)
16%
Monkey
16%
Viral Replication
16%
Live Attenuated
16%
Etiological Agents
16%
Vaccine Candidate
16%
Virus Replication
16%
Live Attenuated Vaccine
16%
Vaccine Virus
16%
Viral Disease
16%
Immunogenic
16%
Next-generation Vaccines
16%
Dengue
16%
Respiratory Syncytial Virus
16%
Peripheral Blood
16%
Rhesus Monkey
16%
Influenza
16%
Live Attenuated Vaccine Candidate
16%
Parainfluenza
16%
Improved Vaccines
16%
Topical Administration
16%
Recombinant Virus
16%
Respiratory Symptoms
16%
Enveloped RNA Viruses
16%
Attenuated Virus
16%
Measles
16%
Pediatric Pulmonary
16%
Mortality Burden
16%
Equal Length
16%
Morbidity Burden
16%
Immunology and Microbiology
Immunogenicity
100%
Attenuated Vaccine
100%
Live Vaccine
100%
Immunology
100%
Granulocyte Macrophage Colony-Stimulating Factor
75%
Viral Replication
50%
Human Parainfluenza Virus 3
50%
Antibody Response
25%
Viral Disease
25%
T Cell
25%
Antibody Blood Level
25%
RNA Virus
25%
Influenza
25%
Human Respiratory Syncytial Virus
25%
Rhesus Monkey
25%
Haplorhini
25%
Dengue Fever
25%
Parainfluenza
25%
Measles
25%
Recombinant Virus
25%
Virus Attenuation
25%